Press Release

Pain Management Devices Market Increase CAGR 9.1% by 2026

Latest Research of Pain Management Devices Market Increase Demand, Growth Opportunities & Industry Trends 2026

The Global Pain Management Devices Market will benefit from increasing regulatory approvals for neuromodulation devices in recent years. According to a report published by Fortune Business Insights, titled “Pain Management Devices: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 3,922.9 Mn in 2018. Fortune Business Insights states that the market will reach US$ 8,046.3 Mn by 2026, exhibiting a CAGR of 9.4%.

Get Sample PDF Brochure @

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/pain-management-devices-market-101069

“Some of the Main Key Players Covered in the Report”Pain Management Devices Market

  • Medtronic
  • Boston Scientific Corporation
  • LivaNova
  • Abbott
  • DJO Global LLC
  • SPR Therapeutics
  • Nevro Corp

Recent technological advancements have opened up a huge pain management devices market growth potential. The report encompasses several factors that have contributed to the growth of the global pain management devices Industry. Besides this, the report includes a few of the factors that have acted as a barrier to market growth and signifies the market strategies adopted by leading companies, specifically aimed at overcoming these barriers.

Browse Complete Report Details @

https://www.fortunebusinessinsights.com/industry-reports/pain-management-devices-market-101069

“Launch of Technologically Advanced Pain Management Devices Likely to Enable Market Growth”

Technological advancements in pain management devices have played a huge part in the overall pain management market growth in recent years. Several companies have launched products with better feasibility and high operational efficacy. In January 2019, Boston Scientific announced the launch of an advanced chronic pain management device, which has been identified as one of the very few devices in the market with the ability to combine paresthesia and sub-perception therapy.

The ‘Spectra WaveWriter SCS System’ was launched with the aim of offering a non-drug therapeutic approach for people suffering from chronic pain. The report encompasses product launches, similar to Boston Scientific’s latest device and signifies the importance and impact of such devices on the global market.

“Segmentation”

By Product Type

  • Electrical Stimulation Devices
  • RF Ablation Devices
  • Neuromodulation Devices
  • Infusion Pumps

By Application

  • Musculoskeletal
  • Brain
  • Cancer
  • Neuropathy

By End User

  • Physiotherapy Centers
  • Hospitals and Clinics

By Geography

  • North America
  • Europe
  • Asia Pacific

Order Full Report: https://www.fortunebusinessinsights.com/checkout-page/101069

“35% Rise in Regulatory Approvals for Pain Management Device Indicates a Huge Potential for Growth in the Foreseeable Future”

As the benefits of pain management devices have been unfolded in recent years, there has been an increase in adoption for these devices across the world. Resulting from the increasing demand for pain management devices, there has been a gradual increase in clinical approvals for these devices in recent years.

According to the International Neuromodulation Society, the total number of approvals for neuromodulation devices from the Food and Drug Administration increased by approximately 35% in the past decade. Fortune Business Insights states that the growing usage approvals will favour the growth of the global pain management devices industry in the forthcoming years.

Fortune Business Insights profiles a few of the companies that have generated substantial pain management market revenue in recent years. Some of the leading companies that are currently operating in the global pain management market are Medtronic, Boston Scientific Corporation, LivaNova, Abbott, DJO Global LLC, SPR Therapeutics, and Nevro Corp.

More Trending Topics from Fortune Business Insights:

Orphan Drugs Market to Reach US$ 294000 Mn by 2025, Increasing Development of Oncology-related Orphan Drugs to Drive the Market: Fortune Business Insights

Transrectal ultrasound (TRUS) Market to reach US$ 291.2 Mn by 2025, Driven by Improvements in Healthcare Infrastructure and Rising Product Availability, says Fortune Business Insights

Breast Cancer Therapeutics Market to Exhibit 10.2% CAGR, Increasing R&D Investment to Boost Growth, says Fortune Business Insights

Tags

Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close